[redacted] [redacted] [redacted]
Currently we are in the process of acquiring a series of clinical testing laboratories as part of an industry consolidation. Our strategy involves acquiring an initial platform company and driving growth by conducting add-on acquisitions of additional clinical laboratories and other complementary businesses. In the process we are interested in gaining additional scale in the test modality of the platform company as well as offering related tests. Our strategy also involves sourcing new testing technologies through a combination of organic and inorganic methods to introduce proprietary new tests and related services.
For context, the value for the platform transaction is approximately $100M with the add on transactions on average ranging from $25 to $40M.
To meet these objectives, we are assembling a team of people with M&A experience in the clinical laboratory industry. The goal is to successfully vet and close a series of transactions and integrate the acquired companies, post-transaction. Timing: Immediate. We are currently in the process of conducting diligence on the initial platform company which we expect to complete in the July time frame. We expect to complete follow-on transactions as well as a conduct post-merger integration projects over a period of 18 to 24 months.
Compensation involves a combination of cash and incentive stock in the holding company.
The role involves the following: Conduct financial modeling of the various companies on a stand-alone (historical) basis as well as on a consolidated (forward looking) basis. Develop various performance scenario analyses based on analysis of bottom-up business drivers. Make recommendations on risks, mitigations, and business strategy. Deep excel modeling experience. We are looking for 2 to 3 individuals to fill this role.
Experience Level: Private equity senior associate level with minimum 5 years-experience.